CYP1A1 inductionDelayed protein and enzyme activity
↓
M
Ligand metabolismDepends on substrate susceptibility
↓
↻
Signal outcomeResolution or persistence
↶
Negative feedbackLigand clearance reduces AhR drive; persistent ligands can escape this loop.
Figures and interactive outputs are conceptual illustrations, not experimental measurements.
01 / LIGAND–FEEDBACK DYNAMICS
Watch the feedback loop respond
Choose a ligand profile and vary induction delay, metabolic capacity and continued exposure.
Live simulation
F
FICZ-like labile profileSusceptible to CYP1-mediated metabolism
Feedback-favored resolution
Ligand availability AhR output CYP1A1 activity
Peak AhR output—
Residual ligand—
Signal persistence—
CYP1A1 is induced after AhR activation; its later metabolism of susceptible ligand contributes to negative feedback.
02 / CIRCUIT COMPONENTS
Explore the control architecture
Choose a node to see how it contributes to signal initiation or resolution.
Interactive circuit
L
INPUT MODULE
Ligand identity shapes the signal
AhR responds to environmental chemicals, dietary compounds, microbial metabolites and endogenous ligands. Ligands differ in receptor engagement and susceptibility to metabolic clearance.
Control questionHow rapidly does the available ligand pool change after exposure?
03 / LIGAND COMPARISON
Same sensor, different persistence
Compare representative ligand behavior described in the review.
Compare profiles
F
FICZ · metabolism-engaged feedback
AhR activation induces CYP1A1, and efficient metabolism of susceptible ligand can lower its availability and shorten the signaling window.
Predicted kinetic signatureLigand decline followed by falling AhR output.
04 / FEEDBACK FAILURE
How can the circuit be uncoupled?
Select a failure mode to see its likely kinetic signature and a way to test it.
Failure explorer
FEEDBACK ESCAPE
Ligand remains available despite CYP1A1 induction
If the ligand is poorly metabolized, enzyme induction may not be sufficient to reduce its availability quickly enough.
Expected patternPersistent ligand and sustained AhR-dependent transcription.
Discriminating testMeasure ligand disappearance, CYP1A1 activity and AhR output in the same time course.
05 / TISSUE REDEPLOYMENT
One circuit, different local outcomes
Explore how shared metabolic feedback can shape distinct tissue functions.
Tissue explorer
BARRIER IMMUNITY
Gut: ligand availability supports mucosal defense
CYP1A1-dependent ligand clearance can shape AhR signaling in intestinal tissues. Constitutive clearance of susceptible ligands can reduce IL-22 production and alter ILC3 and Th17-related mucosal responses.
What to monitorLigand levels, CYP1A1 activity, AhR targets and IL-22-associated readouts.
06 / IMMUNE CONSEQUENCES
Signal timing shapes immune interpretation
Explore outcomes associated with different AhR signal histories.
Immune explorer
▤
Barrier defense depends on ligand dynamics
AhR ligand availability helps regulate intestinal immune and epithelial programs. CYP1A1-mediated clearance can tune this signal, including IL-22-linked mucosal defense.
InterpretationMeasure ligand metabolism and immune output together rather than treating CYP1A1 only as an activation marker.
07 / EXPERIMENT DESIGN
Build a feedback-discrimination experiment
Select a perturbation and a measurement to generate model-specific predictions and controls.
Study planner
Choose settings, then generate an experiment plan.
EXPERIMENT PREDICTION
Ligand pulse and washout
Ligand pulse→Feedback delay→Resolution
Sample before, during and after exposure to distinguish receptor activation from metabolism-driven signal termination.
DETOXIFICATION-FOCUSED VIEW
CYP1A1 induction indicates an AhR-dependent metabolic response.
METABOLIC FEEDBACK VIEW
The time course tests whether CYP1A1 activity is followed by ligand loss and declining AhR output.
Primary readoutLigand disappearance and metabolite appearance
Essential controlVehicle, washout verification and matched sampling.
Discriminating resultCYP1A1-dependent changes in ligand persistence that precede altered AhR output.
C
THE CENTRAL DISTINCTION
CYP1A1 does more than mark AhR activation.
By metabolizing susceptible ligands, it can help determine how long environmental sensing remains active and thereby shape tissue and immune outcomes.